2024

• Lønning, Per Eystein; Nikolaienko, Oleksii; Knappskog, Stian (2024). Constitutional BRCA1 Epimutations: A Key for Understanding Basal-Like Breast and High-Grade Serous Ovarian Cancer. (ekstern lenke)

2023

• Nikolaienko, Oleksii; Eikesdal, Hans Petter; Berge, Elisabet Ognedal et al. (2023). Prenatal BRCA1 epimutations contribute significantly to triple-negative breast cancer development. (ekstern lenke)
• Nikolaienko, Oleksii; Lønning, Per Eystein; Knappskog, Stian (2023). epialleleR: an R/Bioconductor package for sensitive allele-specific methylation analysis in NGS data. (ekstern lenke)
• Yndestad, Synnøve; Engebrethsen, Christina; Herencia-Ropero, A. et al. (2023). Homologous Recombination Deficiency Across Subtypes of Primary Breast Cancer. (ekstern lenke)

2022

• Lønning, Per Eystein; Nikolaienko, Oleksii; Pan, Kathy et al. (2022). Constitutional BRCA1 methylation and risk of incident triple-negative breast cancer and high-grade serous ovarian cancer. (ekstern lenke)
• Nikolaienko, Oleksii; Lønning, Per Eystein; Knappskog, Stian (2022). ramr: an R/Bioconductor package for detection of rare aberrantly methylated regions. (ekstern lenke)

2021

• Venizelos, Andreas; Elvebakken, Hege; Perren, Aurel et al. (2021). The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms. (ekstern lenke)

2020

• Eriksen, Maria Steene; Nikolaienko, Oleksii; Hallin, Erik Ingmar et al. (2020). Arc self‐association and formation of virus‐like capsids are mediated by an N‐terminal helical coil motif. (ekstern lenke)

2018

• Hallin, Erik Ingmar; Eriksen, Maria Steene; Baryshnikov, Sergei et al. (2018). Structure of monomeric full‐length ARC sheds light on molecular flexibility, protein interactions, and functional modalities. (ekstern lenke)

2017

• Nikolaienko, Oleksii; Eriksen, Maria Steene; Patil, Sudarshan et al. (2017). Stimulus-evoked ERK-dependent phosphorylation of activity-regulated cytoskeleton-associated protein (Arc) regulates its neuronal subcellular localization. (ekstern lenke)
• Myrum, Craig; Nikolaienko, Oleksii; Bramham, Clive R. et al. (2017). Implication of the APP gene in intellectual abilities. (ekstern lenke)
• Gozdz, Agata; Nikolaienko, Oleksii; Urbanska, Malgorzata et al. (2017). GSK3α and GSK3β Phosphorylate Arc and Regulate its Degradation. (ekstern lenke)
• Nikolaienko, Oleksii; Patil, Sudarshan; Eriksen, Maria Steene et al. (2017). Arc protein: a flexible hub for synaptic plasticity and cognition. (ekstern lenke)

2015

• Morderer, Dmytro Ye; Nikolaienko, Oleksii; Rynditch, Alla V. (2015). Identificationof Ca2/calmodulin-dependentphosphorylation sites of endocytic scaffold ITSN1 by tandem mass spectrometry. (ekstern lenke)

2013

• Eriksen, Maria Steene; Bramham, Clive R.; Nikolaienko, Oleksii (2013). In search of a binding site for extracellular signal-regulated kinase (ERK) to the synaptic plasticity-related protein Arc. (ekstern lenke)

2004

• Tsyba, Lyudmyla; Skrypkina, Inessa; Rynditch, Alla V. et al. (2004). Alternative splicing of mammalian Intersectin 1: domain associations and tissue specificities.. (ekstern lenke)

Se en full oversikt over publikasjoner i Cristin

Up-to-date publication list at PubMed, ORCID. List of preprints at bioRxiv, medRxiv.

Three most recent publications from CRIStin (might be outdated):

Principal Investigator:

1. 2025/07-2028/06 — Mosaic epimutations: population prevalence, mechanistic origins, and their role in cancer (Research Council of Norway, ~1 MEUR)
2. 2025/01-2027/12 — Mosaic epimutations: population prevalence, mechanistic origins, and their role in cancer (Norwegian Cancer Society, ~680 kEUR)
3. 2024/01-2025/12 — Low-level epimutational mosaicism in tumour suppressor genes—a generic cancer risk factor (Norwegian Cancer Society, ~170 kEUR)
4. 2015/01-2017/12 — Translational neuropsychiatry: impact of genetic variations in synaptic plasticity-related genes (Bergens Forskningsstiftelse / Trond Mohn Research Foundation, ~370 kEUR)

Project Participant:

1. 2022/01-2024/12 — Epimutations in MGMT and MLH1 and risk of cancers of the colon, endometrium and glioblastomas (Western Norway Regional Health Authority, ~450 kEUR)